 | • レポートコード：GIR-23F3965 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Zoster Vaccine Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の帯状疱疹ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 帯状疱疹ワクチン市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・生ワクチン、組換えワクチン アプリケーション別セグメントは次のように区分されます。 ・政府機関、民間、その他 世界の帯状疱疹ワクチン市場の主要なマーケットプレーヤーは以下のとおりです。 ・GSK、Merck、Sanofi Pasteur 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 帯状疱疹ワクチンの概要 - タイプ別分析（2017年vs2021年vs2028年）：生ワクチン、組換えワクチン - アプリケーション別分析（2017年vs2021年vs2028年）：政府機関、民間、その他 - 世界の帯状疱疹ワクチン市場規模・予測 - 世界の帯状疱疹ワクチン生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - GSK、Merck、Sanofi Pasteur ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：生ワクチン、組換えワクチン ・アプリケーション別分析2017年-2028年：政府機関、民間、その他 ・帯状疱疹ワクチンの北米市場分析 - 帯状疱疹ワクチンの北米市場：タイプ別市場規模2017年-2028年 - 帯状疱疹ワクチンの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・帯状疱疹ワクチンのヨーロッパ市場分析 - ：帯状疱疹ワクチンのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：帯状疱疹ワクチンのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・帯状疱疹ワクチンのアジア太平洋市場分析 - 帯状疱疹ワクチンのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 帯状疱疹ワクチンのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・帯状疱疹ワクチンの南米市場分析 - 帯状疱疹ワクチンの南米市場：タイプ別市場規模2017年-2028年 - 帯状疱疹ワクチンの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・帯状疱疹ワクチンの中東・アフリカ市場分析 - 帯状疱疹ワクチンの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 帯状疱疹ワクチンの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Zoster Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Zoster Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Government Institution accounting for % of the Zoster Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Zoster Vaccine include GSK, Merck, Sanofi Pasteur, , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Zoster Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live
Recombinant
Market segment by Application can be divided into
Government Institution
Private Sector
Other
The key market players for global Zoster Vaccine market are listed below:
GSK
Merck
Sanofi Pasteur
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Zoster Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Zoster Vaccine, with price, sales, revenue and global market share of Zoster Vaccine from 2019 to 2022.
Chapter 3, the Zoster Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Zoster Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Zoster Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Zoster Vaccine.
Chapter 13, 14, and 15, to describe Zoster Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Zoster Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Zoster Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live
1.2.3 Recombinant
1.3 Market Analysis by Application
1.3.1 Overview: Global Zoster Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Global Zoster Vaccine Market Size & Forecast
1.4.1 Global Zoster Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Zoster Vaccine Sales in Volume (2017-2028)
1.4.3 Global Zoster Vaccine Price (2017-2028)
1.5 Global Zoster Vaccine Production Capacity Analysis
1.5.1 Global Zoster Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Zoster Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Zoster Vaccine Market Drivers
1.6.2 Zoster Vaccine Market Restraints
1.6.3 Zoster Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Zoster Vaccine Product and Services
2.1.4 GSK Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Zoster Vaccine Product and Services
2.2.4 Merck Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business
2.3.3 Sanofi Pasteur Zoster Vaccine Product and Services
2.3.4 Sanofi Pasteur Zoster Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Zoster Vaccine Breakdown Data by Manufacturer
3.1 Global Zoster Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Zoster Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Zoster Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Zoster Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Zoster Vaccine Manufacturer Market Share in 2021
3.5 Global Zoster Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Zoster Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Zoster Vaccine Market Size by Region
4.1.1 Global Zoster Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Zoster Vaccine Revenue by Region (2017-2028)
4.2 North America Zoster Vaccine Revenue (2017-2028)
4.3 Europe Zoster Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Zoster Vaccine Revenue (2017-2028)
4.5 South America Zoster Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Zoster Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Zoster Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Zoster Vaccine Revenue by Type (2017-2028)
5.3 Global Zoster Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Zoster Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Zoster Vaccine Revenue by Application (2017-2028)
6.3 Global Zoster Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Zoster Vaccine Sales by Type (2017-2028)
7.2 North America Zoster Vaccine Sales by Application (2017-2028)
7.3 North America Zoster Vaccine Market Size by Country
7.3.1 North America Zoster Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Zoster Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Zoster Vaccine Sales by Type (2017-2028)
8.2 Europe Zoster Vaccine Sales by Application (2017-2028)
8.3 Europe Zoster Vaccine Market Size by Country
8.3.1 Europe Zoster Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Zoster Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Zoster Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Zoster Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Zoster Vaccine Market Size by Region
9.3.1 Asia-Pacific Zoster Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Zoster Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Zoster Vaccine Sales by Type (2017-2028)
10.2 South America Zoster Vaccine Sales by Application (2017-2028)
10.3 South America Zoster Vaccine Market Size by Country
10.3.1 South America Zoster Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Zoster Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Zoster Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Zoster Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Zoster Vaccine Market Size by Country
11.3.1 Middle East & Africa Zoster Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Zoster Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Zoster Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Zoster Vaccine
12.3 Zoster Vaccine Production Process
12.4 Zoster Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Zoster Vaccine Typical Distributors
13.3 Zoster Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Zoster Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Zoster Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Zoster Vaccine Product and Services
Table 6. GSK Zoster Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Zoster Vaccine Product and Services
Table 10. Merck Zoster Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Pasteur Major Business
Table 13. Sanofi Pasteur Zoster Vaccine Product and Services
Table 14. Sanofi Pasteur Zoster Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Global Zoster Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 16. Global Zoster Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 17. Market Position of Manufacturers in Zoster Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 18. Global Zoster Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 19. Head Office and Zoster Vaccine Production Site of Key Manufacturer
Table 20. Zoster Vaccine New Entrant and Capacity Expansion Plans
Table 21. Zoster Vaccine Mergers & Acquisitions in the Past Five Years
Table 22. Global Zoster Vaccine Sales by Region (2017-2022) & (K Units)
Table 23. Global Zoster Vaccine Sales by Region (2023-2028) & (K Units)
Table 24. Global Zoster Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 25. Global Zoster Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 26. Global Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 27. Global Zoster Vaccine Sales by Type (2023-2028) & (K Units)
Table 28. Global Zoster Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 29. Global Zoster Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 30. Global Zoster Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 31. Global Zoster Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 32. Global Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 33. Global Zoster Vaccine Sales by Application (2023-2028) & (K Units)
Table 34. Global Zoster Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 35. Global Zoster Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 36. Global Zoster Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 37. Global Zoster Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 38. North America Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 39. North America Zoster Vaccine Sales by Country (2023-2028) & (K Units)
Table 40. North America Zoster Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. North America Zoster Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. North America Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. North America Zoster Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. North America Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 45. North America Zoster Vaccine Sales by Application (2023-2028) & (K Units)
Table 46. Europe Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 47. Europe Zoster Vaccine Sales by Country (2023-2028) & (K Units)
Table 48. Europe Zoster Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 49. Europe Zoster Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 50. Europe Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Europe Zoster Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Europe Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Europe Zoster Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. Asia-Pacific Zoster Vaccine Sales by Region (2017-2022) & (K Units)
Table 55. Asia-Pacific Zoster Vaccine Sales by Region (2023-2028) & (K Units)
Table 56. Asia-Pacific Zoster Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 57. Asia-Pacific Zoster Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 58. Asia-Pacific Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. Asia-Pacific Zoster Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. Asia-Pacific Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. Asia-Pacific Zoster Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. South America Zoster Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. South America Zoster Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. South America Zoster Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. South America Zoster Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. South America Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. South America Zoster Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. South America Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. South America Zoster Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Middle East & Africa Zoster Vaccine Sales by Region (2017-2022) & (K Units)
Table 71. Middle East & Africa Zoster Vaccine Sales by Region (2023-2028) & (K Units)
Table 72. Middle East & Africa Zoster Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 73. Middle East & Africa Zoster Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 74. Middle East & Africa Zoster Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Middle East & Africa Zoster Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Middle East & Africa Zoster Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Middle East & Africa Zoster Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Zoster Vaccine Raw Material
Table 79. Key Manufacturers of Zoster Vaccine Raw Materials
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Zoster Vaccine Typical Distributors
Table 83. Zoster Vaccine Typical Customers
List of Figures
Figure 1. Zoster Vaccine Picture
Figure 2. Global Zoster Vaccine Revenue Market Share by Type in 2021
Figure 3. Live
Figure 4. Recombinant
Figure 5. Global Zoster Vaccine Revenue Market Share by Application in 2021
Figure 6. Government Institution
Figure 7. Private Sector
Figure 8. Other
Figure 9. Global Zoster Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Zoster Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Zoster Vaccine Sales (2017-2028) & (K Units)
Figure 12. Global Zoster Vaccine Price (2017-2028) & (USD/Unit)
Figure 13. Global Zoster Vaccine Production Capacity (2017-2028) & (K Units)
Figure 14. Global Zoster Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Zoster Vaccine Market Drivers
Figure 16. Zoster Vaccine Market Restraints
Figure 17. Zoster Vaccine Market Trends
Figure 18. Global Zoster Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Zoster Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Zoster Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Zoster Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Zoster Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Zoster Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Zoster Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Zoster Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Zoster Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Zoster Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Zoster Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Zoster Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Zoster Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Zoster Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Zoster Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Zoster Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Zoster Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Zoster Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Zoster Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Zoster Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Zoster Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Zoster Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Zoster Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Zoster Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Zoster Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Zoster Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Zoster Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Zoster Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Zoster Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Zoster Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Zoster Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Zoster Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Zoster Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Zoster Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Zoster Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Zoster Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Zoster Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Zoster Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Zoster Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Zoster Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Zoster Vaccine
Figure 78. Zoster Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
• 日本語訳：帯状疱疹ワクチンのグローバル市場2022年
• レポートコード：GIR-23F3965 ▷ お問い合わせ（見積依頼・ご注文・質問）